Search the Newsreel

Emergent BioSolutions (NYSE: EBS) posts Q2 loss, plans cost-cutting

Kaplan Fox Shareholder Alert: Deadline to Lead in the Securities Fraud Lawsuit Against Cogent Communications Holdings, Inc. (NASDAQ: CCOI) is September 21, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Cogent Communications Holdings, Inc. (NASDAQ: CCOI) on behalf of investors who purchased securities between February 29, 2024, and May 1, 2026. The lawsuit alleges that Cogent misrepresented the strength and growth of …

Argent BioPharma Advances CannEpil into U.S. Veterinary Market with New Development Program

Is Emergent BioSolutions Inc (EBS) Overvalued After Q2 Earnings

Emergent BioSolutions Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:EBS) 2026-08-05

Key Points Interested in Emergent Biosolutions Inc.? Here are five stocks we like better. Q2 performance exceeded expectations: Revenue reached $234 million and adjusted EBITDA rose to $97 million, driven by accelerated medical countermeasure deliveries and strong U.S. government contract activity. NARCAN competition is …

Emergent BioSolutions Reports Second Quarter 2026 Financial Results

Emergent BioSolutions announced its second-quarter 2026 financial results, reporting total revenues of $234.3 million, a 66% increase year-over-year, and an adjusted net income of $30.9 million, up 134%. Despite a significant net loss due to a non-cash impairment charge, the company is implementing a …

COGENT CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Cogent Communications Holdings, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Cogent (CCOI) To Contact Him Directly To Discuss Their Options If you purchased or acquired Cogent common stock between February 29, 2024 and May 1, 2026 and would like …

Emergent records $191.3M non-cash charge related to NARCAN asset group

Emergent BioSolutions reported Q2 2026 total revenues of $234.3 million, a 66% increase year-over-year, driven primarily by higher U.S. government sales of smallpox and other medical countermeasure products. Despite this revenue growth and improved adjusted net income and EBITDA, the company posted a GAAP …

Emergent BioSolutions Commits to Cross-Sector Collaboration Against Biological Threats in an Evolving Global Security Environment

Emergent BioSolutions (NYSE: EBS) emphasizes the critical need for cross-sector collaboration to address evolving biological threats stemming from geopolitical conflicts, AI, and synthetic biology. The company highlights calls from European health officials and AI industry leaders for stronger safeguards and points to recent anthrax-related …

Telecom Argentina SA Class B Revenue Breakdown – BCBA:TECO2

Telecom Argentina SA Class B (BCBA:TECO2) generated 8.33 trillion ARS last year, with its Information and Communications Technology Services segment contributing 5.28 trillion ARS. The majority of the company's revenue, 8.03 trillion ARS, originated from Argentina.

Kessler Topaz Meltzer & Check, LLP Announces That a Securities Fraud Class Action Lawsuit Has Been Filed Against Cogent Communications Holdings, Inc.

Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action lawsuit against Cogent Communications Holdings, Inc. (NASDAQ: CCOI). The lawsuit, filed on behalf of investors who purchased Cogent common stock between February 29, 2024, and May 1, 2026, alleges material misstatements …

Intelligent Bio Solutions Completes Usability Study for Fingerprinting Drug Screen; 510(k) on Track

Intelligent Bio Solutions (INBS) has successfully completed a usability study for its Intelligent Fingerprinting Drug Screening System, demonstrating that non-specialist operators can accurately administer the system. This study, which involved 15 trained operators and followed FDA and ICH GCP standards, supports the company's 510(k) …

Intelligent Bio Solutions completes usability study for FDA filing

Intelligent Bio Solutions Inc. (NASDAQ:INBS) announced the successful completion of a usability study for its Intelligent Fingerprinting Drug Screening System. This study is a critical component of its FDA 510(k) submission for U.S. market clearance, specifically to detect the opiate codeine. The results demonstrated …

CCC Intelligent Solutions (NASDAQ: CCC) holder reports small Principal Global Investors stake

Principal Global Investors has reported a small stake in CCC Intelligent Solutions Holdings Inc. (NASDAQ: CCC) through a Schedule 13G/A filing. The firm beneficially owns 6,646 shares, representing 0% of the class, all with shared voting and dispositive power. This filing indicates that Principal …

CCOI UPCOMING DEADLINE: Levi & Korsinsky Alerts COGENT COMMUNICATIONS HOLDINGS, INC. Stockholders of Securities Class Action - Contact the Firm

Levi & Korsinsky, LLP has filed a securities class action lawsuit against Cogent Communications Holdings, Inc. (NASDAQ: CCOI) on behalf of investors who purchased stock between February 29, 2024, and May 1, 2026. The lawsuit alleges that CCOI shares lost over 80% of their …

15 Operators Used Intelligent Bio Solutions' Drug Test Without Lab Training

Intelligent Bio Solutions (Nasdaq: INBS) announced the successful completion of a Usability Study for its Intelligent Fingerprinting Drug Screening System. The study confirmed that 15 non-specialist operators could accurately administer the drug test, supporting its FDA 510(k) submission for U.S. market clearance to detect …

Lithium Argentina Closes $220M Debt Facilities | LAR Stock News

Lithium Argentina (LAR) has secured $220 million in new unsecured debt facilities for its Cauchari-Olaroz lithium brine operation, aimed at funding a Stage 2 expansion to add 45,000 tonnes per annum of lithium carbonate equivalent production. The financing includes a $50 million two-year facility …

Lithium Argentina Announces $220 Million of New Debt Facilities Closed at Cauchari-Olaroz

Lithium Argentina announced the closing of $220 million in new unsecured debt facilities for its Cauchari-Olaroz lithium brine operation. These facilities, consisting of a $50 million and a $170 million credit line, will strengthen the company's financial position and provide funding flexibility for its …

VGNT SEC Filings - Versigent PLC 10-K, 10-Q, 8-K Forms

This page provides a comprehensive resource for Versigent PLC (VGNT) SEC filings, including 10-K, 10-Q, 8-K forms, and insider trading reports. Each filing is enhanced with AI-generated summaries, sentiment and impact scores from Rhea-AI, and end-of-day stock performance data. The platform aims to simplify …

Versigent (NYSE: VGNT) lifts 2026 sales outlook, declares dividend

Versigent PLC reported strong Q2 2026 results, with net sales up 10.8% to $2,444 million and Adjusted EBITDA increasing by 24.8% to $272 million. The company raised and narrowed its full-year 2026 net sales guidance to $9,400-$9,600 million and declared an inaugural quarterly cash …

Fulgent Genetics (FLGT) Stock Gets Fair Value Boost After Analysts Raised Targets

Earnings call transcript: Emergent BioSolutions Q2 2026 revenue tops guidance

This article provides the Q2 2026 earnings report for Emergent BioSolutions. It is a quarterly filing (10-Q) that details the company's financial performance during the second quarter of 2026.

Gentherm (THRM) plans $882M all-stock merger for Modine’s Performance Technologies arm

Emergent Biosolutions (NYSE:EBS) Announces Quarterly Earnings Results

Why Gentrack Group Limited (NZSE:GTK) Could Be Worth Watching

Banco Bilbao Vizcaya Argentaria SA (BBVA) Gewinnprognose: Zukünftige EPS & Umsatzwachstumsprognosen

Cogent (CCOI) Reports Q2: Everything You Need To Know Ahead Of Earnings

(BBVA) as a Liquidity Pulse for Institutional Tactics

This article provides an AI-driven analysis of Banco Bilbao Vizcaya Argentaria S.a. (NASDAQ: BBVA), highlighting strong sentiment across all time horizons and compelling upside potential due to the absence of resistance levels above the current price. It outlines specific institutional trading strategies, including long, …

Kaplan Fox Announces a Securities Class Action Filed Against Cogent Communications Holdings, Inc. (NASDAQ: CCOI) - Lead Plaintiff Deadline is September 21, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Cogent Communications Holdings, Inc. (NASDAQ: CCOI) on behalf of investors who purchased securities between February 29, 2024, and May 1, 2026. The lawsuit alleges that Cogent misrepresented the demand for optical wavelengths …

Price to earnings forward of Argent Biopharma Ltd – ASX:RGT

Cogent Biosciences Gains as Investors Revisit Late-Stage Bezuclastinib Catalysts

Cogent Biosciences (COGT) shares rose 10.2% due to renewed investor optimism regarding its drug bezuclastinib and a busy regulatory schedule. The company recently submitted its third NDA for bezuclastinib in six months, with decisions for other applications expected later in 2026. Cogent is also …

Versigent PLC (VGNT) (Q2 2026) Earnings Call Highlights: Record Launches and Dividend ... By GuruFocus

Versigent PLC reported strong Q2 2026 results with an 11% increase in net sales to $2.4 billion and a 25% rise in adjusted EBITDA. The company achieved record launch activity, secured $2.8 billion in new awards, and initiated its first quarterly dividend of $0.13 …

Ternium Argentina S.A. presenta sus resultados del segundo trimestre y del primer semestre de 2026

Intelligent Protection Invites Questions Before Aug. 11 Call

GENTEX CORP 2026: Revenue $651.3M, EPS $0.54— 10-Q Summary

Gentex Corp (GNTX) reported its 2026 results, with revenue at $651.3 million and diluted EPS of $0.54. Net income increased to $114.69 million, representing a 19.4% rise year-over-year. The company saw consolidated revenue up 7% year-to-date, strong Premium Audio performance, and plans for a …

Telecom Argentina Stet - France Telecom (TEO) to Release Earnings on Tuesday